1.430USD+1.42%Mkt Cap: —P/E: —1d ago
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics. The Pharmaceutic…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value1.12B $
Revenue (TTM)587.90M $
Gross Profit115.49M $
Net Income (TTM)-72.89M $
Revenue/Share0.7540 USD
Last Price1.430 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.3K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISINUS68375N1037
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-14.32
EV/Revenue1.90
P/S—
P/B0.86
EPS (TTM)-0.18
EPS (Forward)—
52W Range
1.34069% of range1.470
52W High1.470 USD
52W Low1.340 USD
Profitability
Gross Margin19.64%
Oper. Margin-15.31%
EBITDA Margin-13.30%
Profit Margin-12.40%
ROE-5.88%
ROA-5.52%
Growth
Revenue Growth4.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-123.38M $
CapEx (TTM)—
FCF Margin9.32%
FCF Yield—
Net Debt97.32M $
Net Debt/EBITDA-1.24
Balance Sheet
Debt/Equity33.62
Current Ratio3.35
Quick Ratio2.65
Book Value/Sh1.587 USD
Cash/Share0.4030 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.559.83M
Float323.73M
Insiders50.52%
Institutions27.51%
Technical
SMA 501.012 (+41.3%)
SMA 2001.474 (-3.0%)
Beta1.49
S&P 52W Chg20.80%
Avg Vol (30d)22.41K
Avg Vol (10d)62.55K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—